Obstetrics & gynaecology

Preclinical study identifies new target for recurrent ovarian cancer

Despite recent advances, ovarian cancer remains the fifth leading cause of cancer-related deaths among women, and there's a critical need for new treatment options, especially for advanced cancers that grow back after standard ...

Medical research

Resistance-fighting antimalarial drug candidate enters the clinic

A new antimalarial drug candidate, discovered through a longstanding collaboration between WEHI and global biopharmaceutical company MSD has entered Phase 1 clinical testing in healthy participants. The candidate drug inhibits ...

Medications

Study finds evidence of resistance to COVID-19 drugs

Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug known as a protease inhibitor could soon become less effective in treating COVID-19 ...

Medical research

Potential treatment target for drug-resistant epilepsy identified

Researchers at Tufts University School of Medicine and colleagues have identified a small molecule that may help treat people with epilepsy whose condition has become resistant to the benzodiazepine drugs usually used in ...

Diseases, Conditions, Syndromes

What happens if we run out of antibiotics?

Widespread use of antibiotics in humans and animals has created growing resistance to treatments. What will happen if nothing is done? We asked expert Piotr Garstecki.

page 12 from 40